UnitedHealth (UNH) director reports 162-share grant

Rhea-AI Filing Summary

UnitedHealth Group (UNH) director Kristen L. Gil received 162 shares of common stock as regular quarterly director compensation on 10/01/2025 at no cash price reported. After the grant, Ms. Gil directly beneficially owns 1,900 shares and indirectly owns 3,800 shares through a trust. The Form 4 was signed by an attorney-in-fact on 10/03/2025. The filing identifies the reporting person as a director and notes the shares were granted as routine director compensation.

Insider Trade Summary

Net Buyer: 162 shares

Net Buy 2 txns

Insider Gil Kristen

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	162	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 1,900 shares (Direct); Common Stock — 3,800 shares (Indirect, By Trust)

Footnotes (1)

1. F1. Represents shares of common stock that are granted as regular quarterly compensation for service as a director of UnitedHealth Group.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 10/03/2025 - 04:19 PM Learn about SEC filing dates

FAQ

What transaction did Kristen L. Gil report on Form 4 for UNH?

Ms. Gil reported the receipt of 162 shares of UnitedHealth Group common stock on 10/01/2025 as director compensation.

How many UNH shares does Kristen L. Gil own after the reported transaction?

Following the grant, Ms. Gil beneficially owns 1,900 shares directly and 3,800 indirectly through a trust.

Was there any purchase price paid for the shares reported in the Form 4?

The transaction lists a price of $0, indicating the shares were granted as compensation rather than purchased.

What is the relationship of the reporting person to UnitedHealth Group?

The Form 4 identifies Kristen L. Gil as a Director of UnitedHealth Group.

Who signed the Form 4 filing for Kristen L. Gil?

The filing was signed by Faraz A. Choudhry, attorney-in-fact, on 10/03/2025.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Gil Kristen

(Last) (First) (Middle)

C/O UNITEDHEALTH GROUP INCORPORATED

1 HEALTH DRIVE

(Street)

EDEN PRAIRIE MN 55344

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
UNITEDHEALTH GROUP INC [ UNH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/01/2025		A		162(1)	A	$0	1,900	D
Common Stock								3,800	I	By Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of common stock that are granted as regular quarterly compensation for service as a director of UnitedHealth Group.

Remarks:

	Faraz A. Choudhry, Attorney-in-Fact for Kristen L. Gil	10/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.